Treatment Options for Colistin Resistant <i>Klebsiella pneumoniae</i>: Present and Future
Multidrug-resistant (MDR) <i>Klebsiella pneumoniae</i> represents an increasing threat to human health, causing difficult-to-treat infections with a high mortality rate. Since colistin is one of the few treatment options for carbapenem-resistant <i>K. pneumoniae infections</i>...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-06-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/8/7/934 |